The trial will assess if the drug may be able to prevent infection among patients who have been exposed and treat those who have been infected with the disease.
No comments yet. Be the first to comment!
More from FoundryBase Forbes
Know a great resource? Login to add your own!
No comments yet. Be the first to comment!